Ken Perry

1.3k citations
17 papers · 983 · 1 hit paper · h-index 11

Impact in

  • Neurology top 2%
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Parkinson's Disease Mechanisms and Treatments
    • Neuroscience and Neuropharmacology Research
    • Neurotransmitter Receptor Influence on Behavior
    • Nerve injury and regeneration
    • Nuclear Receptors and Signaling

Papers in

Ken Perry

17 papers receiving 969 citations

Ken Perry's Hit Papers

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease 2001 · 657 citations
6570+8+16Years since publication200400600

Peers

Ken Perry
Comparison fields: 5 of 101
  • Neurology 324
  • Cellular and Molecular Neuroscience 463
  • Neurology 293
  • Biological Psychiatry 45
  • Developmental Neuroscience 48
Replace Mei Yu with:
Mei Yu China
Wei Dong Le United States
Milica Cerovic Italy
Mary B. Newman United States
Ilse S. Pienaar United Kingdom
Corinne Brana France
Mélanie Bourque Canada
Sufen Yang United States
Anne Michel Belgium
Bo Tian China
Ken Perry relative to Mei Yu China Mei Yu's profile →
Citations per field
00.5×1.5×
Mei Yu · 1×
Citations per year

Countries citing papers authored by Ken Perry

Since Specialization
Citations

This map shows the geographic impact of Ken Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Perry more than expected).

Fields of papers citing papers by Ken Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Perry. The network helps show where Ken Perry may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Perry Line = papers co-authored together Ken Perry links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
Hit paper breakdown →
2001657
2 199459
3 199451
4 199338
5 199334
6 201330
7 200326
8 197525
9 199722
10 200311
11 199310
12 20228
13 20216
14
Habitat monitoring for conservation management and reporting
20012
15 19982
16 19961
17 20021

About Ken Perry

Ken Perry is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health, Molecular Biology, Neurology and Organic Chemistry, having authored 17 papers that have together received 983 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Attention Deficit Hyperactivity Disorder (5 papers), Receptor Mechanisms and Signaling (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Epilepsy research and treatment (1 paper), Ion Transport and Channel Regulation (1 paper) and Molecular Sensors and Ion Detection (1 paper). The work is most often cited by research in Neurology (324 citations), Cellular and Molecular Neuroscience (463 citations), Neurology (293 citations), Biological Psychiatry (45 citations) and Developmental Neuroscience (48 citations). Ken Perry has collaborated with scholars based in United States, Poland and Singapore. Frequent co-authors include Ray W. Fuller, Lee A. Phebus, Frank P. Bymaster, Steven M. Paul, Eyassu Chernet, Suizhen Lin, Feng Gao, Richard Dodel, Yansheng Du and Zhizhong Ma. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Developmental Brain Research, Journal of the Peripheral Nervous System, Schizophrenia Research and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact